CTRI/2020/10/028708已完成4 期
: Post Marketing, Single Arm, Observational Clinical Registry to Evaluate Safety and Efficacy of 0.9% Sodium Chloride Eye Wash in all comers real-world population - Not applicable
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 188
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Inclusion Criteria:
- •1. Patients above >=18 years of age.
- •2. Patients who are able to give voluntary, written informed consent to participate in this clinical investigation and from whom consent has been obtained.
- •3. Patients having moderate to severe symptoms suggestive of conditions such as irritation, discomfort, burning, stinging and itching due to loose foreign material in the eyes wherein the study product would be prescribed by Investigator as part of standard of care.
- •4. Patients who have been prescribed study product by Investigator as part of standard of care (SOC) practice and consent has been provided by patient post prescription of study product on the same day.
排除标准
- •Exclusion Criteria:
- •1. Patients having any ocular diseases (corneal abrasion, ocular infection, foreign body trapping or ocular trauma), present or past, other than dry eye
- •2. History of ocular surgery
- •3. Patients using contact lens or topic treatments other than tear substitutes
- •4. History of intolerance or hypersensitivity to any component of the study medications
- •5. Patients participating in any other clinical trial during study
- •6. Pregnant/lactating women during study period.
研究者
相似试验
进行中(未招募)
Unknown
A Post Marketing Surveillance study of gadodiamideCTRI/2023/05/053235GE HealthCare Ltd
已完成
4 期
Observation clinical registry study to evaluate safety and efficacy of 0.5% carboxymethylcellulose in dry eye disease patientsCTRI/2020/10/028479Amanta Healthcare Limited315
已完成
4 期
Observation clinical registry study to evaluate safety and efficacy of 0.9% sodium chloride wound irrigation solution in patients having moderate to severe woundsCTRI/2020/10/028494Amanta Healthcare Limited188
招募中
4 期
A Study to assess the safety and efficacy of FDC of Propranolol Hydrochloride IP Plus Clonazepam IP Tablets in patients with anxiety disorders.CTRI/2020/07/026634Akums Drugs Pharmaceuticals Limited
已完成
4 期
Post marketing observational study in Allergic rhinitis (group of symptoms affecting the nose) and Urticaria (Hives) patients to know the effectiveness of LevocetirizineCTRI/2022/04/041937Dr Reddys Laboratories110
